دورية أكاديمية
Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial
| العنوان: | Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial |
|---|---|
| المؤلفون: | Tabernero, J., Taieb, J., Fakih, M., Prager, G.W., Van Cutsem, E., Ciardiello, F., Mayer, R.J., Amellal, N., Skanji, D., Calleja, E., Yoshino, T. |
| المساهمون: | Servier Institute |
| المصدر: | ESMO Open ; volume 9, issue 3, page 102945 ; ISSN 2059-7029 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.esmoop.2024.102945 |
| الإتاحة: | https://doi.org/10.1016/j.esmoop.2024.102945Test https://api.elsevier.com/content/article/PII:S2059702924007130?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2059702924007130?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.40F02876 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.esmoop.2024.102945 |
|---|